BioTie Therapies

BioTie Therapies Corp. is a biopharmaceutical company primarily focused on developing and marketing treatments for central nervous system disorders in Finland and the United States. The company offers Selincro (nalmefene), a dual-acting opioid system modulator that reduces alcohol consumption in individuals with alcohol dependence. It has several innovative small molecule and biologic drug candidates at various stages of clinical development.